Delivery Order V797D60717-VA77017F0236
Award Date
11/28/16
Potential Completion Date
12/16/16
Potential Value
$302K
Funding Federal Agency
Veterans Integrated Service Network 12
Contracting Federal Agency
Veterans Integrated Service Network 15
Awardee
Kaleo, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Richmond, VA 23219, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Kaleo, Inc. for NALOXONE AUTO INJECTORS has a ceiling value of $452,310.00. The contract was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12, and is a firm fixed-price purchase order with an ultimate completion date of August 17, 2016. The contract does not have a set-aside designation. Kaleo, Inc. is a pharmaceutical company specializing in auto-injector technologies for life-saving medications, and...
This is a federal contract awarded by the U.S. Department of Veterans Affairs (VA) to Kaleo, Inc., a pharmaceutical company specializing in auto-injector technologies for critical medications. The contract, valued at $700,000.00, is for the delivery of naloxone injectors.
The contract does not have a set-aside designation. It was awarded under the GSA Pharmaceutical and Drugs Schedule (FSS-61-IB) and is a firm fixed-price delivery order. Kaleo, Inc. is a prime contractor with significant...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Kaleo, Inc., a small business manufacturer of pharmaceutical auto-injector devices. The $452,310.00 contract is to provide naloxone auto-injectors, which are critical life-saving medications used to address the opioid crisis. Kaleo is a key supplier of emergency response products to federal agencies, having received multiple awards from the Department of Health...
This is a federal contract award to Kaleo, Inc., a Richmond, VA based pharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide Naloxone Injector Kits. The contract is a Delivery Order under the VA's Federal Supply Schedule (FSS-61-IB) Pharmaceuticals and Drugs contract, with a Firm Fixed Price of $198,000.00. Kaleo has held multiple federal contracts to provide medical countermeasures and pharmaceuticals, including awards from the...
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded Kaleo, Inc., a $30,344,948.00 cost-plus-fixed-fee contract for the development of a novel pralidoxime chloride auto-injector device. This contract supports ASPR's Biomedical Advanced Research and Development Authority (BARDA) program, which focuses on medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray. The contract is a firm-fixed price order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, with a potential value of $904,465.44. The contract does not have a set-aside designation. Naloxone is a medication that rapidly reverses opioid overdoses and is used...
The Department of Veterans Affairs Veterans Health Administration awarded a $672,672.00 Firm Fixed Price Delivery Order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of the opioid overdose reversal medication naloxone. This order is under Emergent Devices' existing Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which runs through August 2028. The contract has no set-aside designation. Emergent Devices has previously received sub-awards from...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceuticals and medical devices, to provide naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. The $946,261.44 firm-fixed-price delivery order was placed against Emergent Devices' Federal Supply Schedule 65 IB contract, which furnishes drugs and hematology...
The Department of Veterans Affairs Veterans Health Administration has awarded a $636,546.00 Firm Fixed Price delivery order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of NALOXONE HCL 4MG/SPRAY SOLN. This order is placed under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract held by Emergent Devices. The contract does not have a set-aside designation. Emergent Devices is a specialty biopharmaceutical company that provides pharmaceuticals,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,454.09 firm fixed-price delivery order is for the supply of 4,566,550,940 units of the Naloxone 10 mg auto-injector (0.4 ml). This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...